Compare CYH & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYH | CION |
|---|---|---|
| Founded | 1985 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 442.5M | 384.8M |
| IPO Year | 2000 | 2011 |
| Metric | CYH | CION |
|---|---|---|
| Price | $3.07 | $6.28 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 6 | 1 |
| Target Price | $3.28 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 1.2M | 535.4K |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 15.96% |
| EPS Growth | ★ 196.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,485,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.17 | N/A |
| P/E Ratio | ★ N/A | $17.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.39 | $6.27 |
| 52 Week High | $4.43 | $10.93 |
| Indicator | CYH | CION |
|---|---|---|
| Relative Strength Index (RSI) | 58.52 | 31.21 |
| Support Level | $3.05 | N/A |
| Resistance Level | $3.25 | $7.23 |
| Average True Range (ATR) | 0.10 | 0.24 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 73.40 | 1.05 |
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Companies portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.